QUALITY INDICATORS OF THE FOURTH SCREENING ROUND (2008-2009) OF THE HUNGARIAN ORGANIZED, NATIONWIDE BREAST CANCER SCREENING PROGRAMME
Author(s)
Boncz I*1;Dobrossy L2;Péntek Z3;Kovács A2;Budai A2;Vajda R1, Sebestyén A4 1University of Pécs, Pécs, Hungary, 2National Public Health and Medical Officers Service (ÁNTSZ), Budapest, Hungary, 3MaMMa Healthcare Ltd, Budapest, Hungary, 4National Health Insurance Fund Administration, Pécs, Hungary
OBJECTIVES: Organized, nationwide screening for breast cancer with mammography started in Hungary in January 2002. Women in the age group 45-65 years are the target population and 2 years screening interval is applied. The aim of this study is to evaluate the quality indicators of the 4th screening round (2008-2009). METHODS: The data derive from the financial database of the National Health Insurance Fund Administration (NHIFA) covering the period of 2008-2009. We calculated the following indicators: recall rate of women who underwent mammography examinations, attendance of re-called women, proportion of women referred to surgery, proportion of women who underwent surgery compared to referred women, proportion of benign and malignant cases. RESULTS: In 2008-2009 there were 477904 screening mammography examinations in Hungary. 5.15 % of participating women were re-called. The attendance of re-called women was 92.25 %. Altogether 2092 women (9.7 %) were referred for breast surgery but only 1485 women (71.0 %) underwent surgery. Histological examination confirmed 281 benign (18.9 %) and 1204 malignant (81.1 %) cases. CONCLUSIONS: The quality indicators of the Hungarian organized mammography screening program met the recommendations of international professional guidelines. However, in addition to current indicators, new ones should be introduced in order to provide a more comprehensive monitoring of the program.
Conference/Value in Health Info
2013-11, ISPOR Europe 2013, The Convention Centre Dublin
Value in Health, Vol. 16, No. 7 (November 2013)
Code
PCN25
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Oncology